This month, The Fass Lane discusses the results of a study assessing the difference between potassium-competitive acid blockers and proton pump inhibitors with respect to short-term adverse events.

The FDA has approved lirafugratinib (Lyrfigtu, Elevar) for the treatment of adults with previously treated unresectable, locally advanced, or metastatic cholangiocarcinoma harboring a fibroblast ...

In this installment of our video series Through the Scope, Rajesh Keswani, MD, MS, demonstrates the importance of careful ...

Being diagnosed with inflammatory bowel disease often leads to isolation, shame, and a lot of potentially embarrassing questions.

Higher preoperative abundance of the periodontal pathogenic bacterium Porphyromonas was associated with an increased risk for recurrence in patients with early-stage colorectal cancer undergoing ...

Two leaders at the forefront of fellowship curriculum design met with GEN recently to discuss the pros and cons shortening ...

A daily dose of aspirin led to a significant reduction in liver fat in patients with metabolic dysfunction–associated steatotic liver disease, according to new research.

Gastroenterology & Endoscopy News is a No. 1-rated independent monthly newspaper providing news and information for more than 20,000 gastroenterologists, colorectal surgeons, hepatologists, physician ...

In this edition of Sharma’s Endoscopy Insights, I review the ideal bowel preparation for patients undergoing small-bowel capsule endoscopy and success rates for a repeat colonoscopy using a standard ...

Esophageal adenocarcinoma is a lethal cancer that has undergone a dramatic increase in incidence over the last few decades. 1 EAC now represents the most common form of esophageal cancer in Western ...

Choosing an Agent An ideal bowel preparation regimen should be maximally efficacious, safe, and tolerable, as well as affordable and easy to use. 3 Tables 1 and 2 list available FDA-approved and ...